Volume today, page-10

Wazza, Many companies receive FDA holds. They're usually resolved promptly, or at least more promptly than the Pran ordeal, and there's not much fuss made and price spikes when the holds are lifted. It's not exactly a badge of honor to call attention to it. Publicizing beyond the expected company announcement usually does not occur.

In any case, removal of the Partial Clinical Hold should be a vast relief after the perpetual waiting - IF Prana will get to work and begin and continue Reach2HD Phase III to completion without any more gaps in time. Also of major importance will be to finally hear of the FDA's recommendation of dosage amount allowed to provide efficacy.